vs

Side-by-side financial comparison of ISABELLA BANK CORP (ISBA) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $21.2M, roughly 1.3× ISABELLA BANK CORP). ISABELLA BANK CORP runs the higher net margin — 22.2% vs -10.3%, a 32.4% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 14.3%). ISABELLA BANK CORP produced more free cash flow last quarter ($23.3M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 12.6%).

The Bank of the Philippine Islands is a universal bank in the Philippines. It is the oldest bank in both the Philippines and Southeast Asia. It is the fourth largest bank in terms of assets, the second largest bank in terms of market capitalization, and one of the most profitable banks in the Philippines.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

ISBA vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.3× larger
NPCE
$26.6M
$21.2M
ISBA
Growing faster (revenue YoY)
NPCE
NPCE
+9.6% gap
NPCE
23.9%
14.3%
ISBA
Higher net margin
ISBA
ISBA
32.4% more per $
ISBA
22.2%
-10.3%
NPCE
More free cash flow
ISBA
ISBA
$22.9M more FCF
ISBA
$23.3M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
12.6%
ISBA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ISBA
ISBA
NPCE
NPCE
Revenue
$21.2M
$26.6M
Net Profit
$4.7M
$-2.7M
Gross Margin
77.4%
Operating Margin
32.2%
-6.6%
Net Margin
22.2%
-10.3%
Revenue YoY
14.3%
23.9%
Net Profit YoY
17.4%
48.0%
EPS (diluted)
$0.64
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISBA
ISBA
NPCE
NPCE
Q4 25
$21.2M
$26.6M
Q3 25
$20.5M
$27.4M
Q2 25
$18.8M
$23.5M
Q1 25
$18.1M
$22.5M
Q4 24
$18.5M
$21.5M
Q3 24
$18.0M
$21.1M
Q2 24
$17.2M
$19.3M
Q1 24
$16.7M
$18.1M
Net Profit
ISBA
ISBA
NPCE
NPCE
Q4 25
$4.7M
$-2.7M
Q3 25
$5.2M
$-3.5M
Q2 25
$5.0M
$-8.7M
Q1 25
$3.9M
$-6.6M
Q4 24
$4.0M
$-5.3M
Q3 24
$3.3M
$-5.5M
Q2 24
$3.5M
$-7.5M
Q1 24
$3.1M
$-8.9M
Gross Margin
ISBA
ISBA
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
ISBA
ISBA
NPCE
NPCE
Q4 25
32.2%
-6.6%
Q3 25
30.7%
-9.5%
Q2 25
32.8%
-29.0%
Q1 25
26.9%
-22.9%
Q4 24
26.0%
-17.0%
Q3 24
21.3%
-20.1%
Q2 24
23.9%
-32.4%
Q1 24
21.8%
-41.6%
Net Margin
ISBA
ISBA
NPCE
NPCE
Q4 25
22.2%
-10.3%
Q3 25
25.6%
-12.8%
Q2 25
26.7%
-36.8%
Q1 25
21.9%
-29.3%
Q4 24
21.6%
-24.5%
Q3 24
18.2%
-25.9%
Q2 24
20.3%
-39.0%
Q1 24
18.7%
-49.2%
EPS (diluted)
ISBA
ISBA
NPCE
NPCE
Q4 25
$0.64
$-0.08
Q3 25
$0.71
$-0.11
Q2 25
$0.68
$-0.26
Q1 25
$0.53
$-0.21
Q4 24
$0.54
$-0.16
Q3 24
$0.44
$-0.19
Q2 24
$0.46
$-0.26
Q1 24
$0.42
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISBA
ISBA
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$26.0M
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$231.4M
$19.0M
Total Assets
$2.2B
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISBA
ISBA
NPCE
NPCE
Q4 25
$26.0M
$61.1M
Q3 25
$161.3M
$60.0M
Q2 25
$108.6M
$62.1M
Q1 25
$69.2M
$66.3M
Q4 24
$24.5M
$52.8M
Q3 24
$27.4M
$56.8M
Q2 24
$23.6M
$55.5M
Q1 24
$25.2M
$58.9M
Stockholders' Equity
ISBA
ISBA
NPCE
NPCE
Q4 25
$231.4M
$19.0M
Q3 25
$227.4M
$18.5M
Q2 25
$220.5M
$19.4M
Q1 25
$215.6M
$24.3M
Q4 24
$210.3M
$8.0M
Q3 24
$213.0M
$9.8M
Q2 24
$202.2M
$9.9M
Q1 24
$200.7M
$14.3M
Total Assets
ISBA
ISBA
NPCE
NPCE
Q4 25
$2.2B
$105.6M
Q3 25
$2.3B
$107.3M
Q2 25
$2.2B
$106.1M
Q1 25
$2.1B
$110.2M
Q4 24
$2.1B
$94.6M
Q3 24
$2.1B
$96.3M
Q2 24
$2.1B
$94.4M
Q1 24
$2.1B
$98.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISBA
ISBA
NPCE
NPCE
Operating Cash FlowLast quarter
$26.8M
$506.0K
Free Cash FlowOCF − Capex
$23.3M
$409.0K
FCF MarginFCF / Revenue
110.2%
1.5%
Capex IntensityCapex / Revenue
16.4%
0.4%
Cash ConversionOCF / Net Profit
5.72×
TTM Free Cash FlowTrailing 4 quarters
$36.0M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISBA
ISBA
NPCE
NPCE
Q4 25
$26.8M
$506.0K
Q3 25
$2.7M
$-1.9M
Q2 25
$7.8M
$-2.1M
Q1 25
$4.7M
$-7.5M
Q4 24
$19.6M
$-4.8M
Q3 24
$3.6M
$-1.7M
Q2 24
$5.5M
$-3.9M
Q1 24
$3.4M
$-7.5M
Free Cash Flow
ISBA
ISBA
NPCE
NPCE
Q4 25
$23.3M
$409.0K
Q3 25
$1.7M
$-2.0M
Q2 25
$7.2M
$-2.3M
Q1 25
$3.7M
$-7.5M
Q4 24
$17.5M
$-4.8M
Q3 24
$3.2M
$-1.8M
Q2 24
$5.1M
$-4.0M
Q1 24
$2.6M
$-7.6M
FCF Margin
ISBA
ISBA
NPCE
NPCE
Q4 25
110.2%
1.5%
Q3 25
8.5%
-7.2%
Q2 25
38.5%
-9.6%
Q1 25
20.6%
-33.4%
Q4 24
94.6%
-22.5%
Q3 24
17.7%
-8.7%
Q2 24
29.8%
-20.6%
Q1 24
15.7%
-42.1%
Capex Intensity
ISBA
ISBA
NPCE
NPCE
Q4 25
16.4%
0.4%
Q3 25
5.0%
0.1%
Q2 25
3.2%
0.7%
Q1 25
5.5%
0.2%
Q4 24
11.4%
0.2%
Q3 24
2.0%
0.5%
Q2 24
2.4%
0.3%
Q1 24
4.9%
0.6%
Cash Conversion
ISBA
ISBA
NPCE
NPCE
Q4 25
5.72×
Q3 25
0.52×
Q2 25
1.56×
Q1 25
1.19×
Q4 24
4.91×
Q3 24
1.08×
Q2 24
1.59×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons